Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease

…, AH MacKenzie, JD Clough, WS Wilke… - The American journal of …, 1990 - Elsevier
purpose: Methotrexate (MTX), when used to treat malignancy or psoriasis, has been implicated
in anecdotal reports as a teratogen or abortifacient in the first trimester of pregnancy. We …

A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis

…, K Kalunian, D Klashman, WS Wilke… - Arthritis & …, 2002 - Wiley Online Library
Objective To evaluate treatment with methotrexate (MTX) in patients with newly diagnosed
giant cell arteritis (GCA) to determine if MTX reduces GCA relapses and cumulative …

Low-dose methotrexate therapy for ocular inflammatory disease

SS Shah, CY Lowder, MA Schmitt, WS Wilke… - Ophthalmology, 1992 - Elsevier
Background: Methotrexate is a second-line anti-inflammatory agent used in the treatment of
rheumatic diseases. At low doses (12.5 mg/week), it is associated with few serious side …

Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate

RS Perhala, WS Wilke, JD Clough… - Arthritis & Rheumatism …, 1991 - Wiley Online Library
We performed a 10‐year retrospective analysis of the frequency of local postoperative
infectious complications in methotrexate (MTX)‐treated rheumatoid arthritis patients who …

Fibromyalgia and obesity: the association between body mass index and disability, depression, history of abuse, medications, and comorbidities

CE Gota, S Kaouk, WS Wilke - JCR: Journal of Clinical …, 2015 - journals.lww.com
Aim The aim of this study was to determine the frequency of increasing body mass index (BMI)
in fibromyalgia (FM) and to understand the impact of increasing BMI on FM. Methods …

Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature

GD Groff, KN Shenberger, WS Wilke… - Seminars in arthritis and …, 1983 - Elsevier
New therapeutic alternatives are needed for patients with progressive RA unresponsive to
gold or d-penicillamine. Azathioprine and cyclophosphamide can be effective but have been …

The impact of depressive and bipolar symptoms on socioeconomic status, core symptoms, function and severity of fibromyalgia

CE Gota, S Kaouk, WS Wilke - International Journal of …, 2017 - Wiley Online Library
Aim To evaluate the prevalence of depressive and bipolar symptoms in a cohort of
consecutive fibromyalgia ( FM ) patients seen in a tertiary care center and to determine the …

Treatment of corticosteroid-resistant giant cell arteritis

WS Wilke, GS Hoffman - Rheumatic Disease Clinics of North America, 1995 - Elsevier
Giant cell arteritis (GCA) is a form of vascular inflammation that preferentially affects medium
and large arteries, including those vessels originating from the aorta. Histopathology shows …

[PDF][PDF] New developments in the diagnosis of fibromyalgia syndrome: say goodbye to tender points

WS Wilke - Cleve Clin J Med, 2009 - scholar.archive.org
The Symptom Intensity Scale score can be used to identify and quantify fibromyalgia syndrome
from information supplied by a simple questionnaire. In this paper, the author describes …

Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (Wegener's)

RA Hajj‐Ali, WS Wilke, LH Calabrese… - Arthritis care & …, 2011 - Wiley Online Library
… Pearson’s chi-square test or Fisher’s exact test were used for the association of the categorical
measures. Binomial test was performed for the frequency comparisons. Scatter plots were …